Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Equity

v3.7.0.1
Condensed Consolidated Statement of Equity - 3 months ended Mar. 31, 2017 - USD ($)
$ in Thousands
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Non-controlling Interest
Total
Balance at Dec. 31, 2016 $ 278 $ (33,068) $ 516,675 $ (422) $ (70,574) $ 398 $ 413,287
Balance (in shares) at Dec. 31, 2016 55,642,686 (12,402,119)          
Increase (decrease) in shareholders' equity              
Exercise of stock options $ 1   1,899       1,900
Exercise of stock options (in shares) 208,334            
Issuance of common stock - vesting of restricted stock units $ 3           3
Issuance of common stock units - vesting of restricted stock (in shares) 513,779            
Stock-based compensation expense     7,761       7,761
Purchase of treasury stock for stock-based tax withholdings   $ (6,650)         (6,650)
Purchase of treasury stock for stock-based tax withholdings (in shares)   (177,027)          
Foreign currency translation loss       733     733
Net loss         (13,135)   (13,135)
Balance at Mar. 31, 2017 $ 282 $ (39,718) $ 526,335 $ 311 $ (83,709) $ 398 $ 403,899
Balance (in shares) at Mar. 31, 2017 56,364,799 (12,579,146)